Healthcare costs in the U.S. remain high and continue to increase for consumers and patients [1].
These rising expenses impact millions of Americans by limiting access to affordable care and placing a heavier financial burden on households. The trend persists despite the original intent of the Affordable Care Act to lower costs for the general population [2].
Recent data shows a significant spike in insurance costs. ACA Marketplace benchmark premiums surged by 21.7% in 2026 [2]. This increase adds to the overall financial pressure on individuals seeking coverage through government-regulated exchanges.
The average annual price per person for healthcare has reached $13,493 [3]. This figure reflects a complex mix of public, private, and partially funded systems that contribute to the high cost of care in the U.S. [1].
Pharmaceutical prices remain a primary driver of these expenses. For example, the cancer drug Keytruda can cost over $150,000 per treatment [4]. Such high costs for life-saving medications create significant barriers for patients who do not have comprehensive insurance coverage.
Experts said that healthcare costs are increasing at the fastest rate since the COVID-19 pandemic [5]. The combination of rising premiums and expensive specialized treatments ensures that the U.S. remains one of the most expensive places in the world to receive medical care.
“ACA Marketplace benchmark premiums surged by 21.7% in 2026”
The continued escalation of medical expenses suggests that legislative efforts to curb costs have not yet offset the pricing power of pharmaceutical companies and insurance providers. As benchmark premiums and drug prices rise, the gap between the cost of care and the average consumer's ability to pay widens, potentially leading to increased medical debt and deferred treatment for chronic conditions.
